reference/29745738

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29745738

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	95
issn	0378-1119
pageRange	85-95
publicationName	Gene
startingPage	85
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3bfb499aa1ad4b7aba4463e38f949121 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_946c9a35a0cb3fb01994406653421918 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6831adef4923e025d256c65e76ee167a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4d1e4542b00f33ad2bfe8b218ddd4ac1 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_bbb4d2031d88726b86947b8001f71fd9
bibliographicCitation	Zhang L, Chen T, Yan L, Xu H, Wang Y, Li Y, Wang H, Chen S, Wang W, Chen C, Yang Q. MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer. Gene. 2019 Jun 05;700():85–95. doi: 10.1016/j.gene.2019.02.066. PMID: 30878390.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97dacca51308bfd7fe4f39acb397bb2e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d53d47891afe3ced6569d61db497a62 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1461c5201c613c35104af21c1fcfd14 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73b61f5a854595326819461e6aa2abea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ec1bcaf548e442c3287cc9c242065db http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_733b84300fb119126f2252debe4a1511 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcd07540611d3cbda450f9cbf7ef0790 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d9adbf8578052e00b01968eaec023be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fa1f6f34b7bed12d744608c11fa7a7a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2d6902f1e9c8623e9d0d52e2a9b9426 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd2c40e530806da242e0882d08a5638c
date	2019-06-05^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/30878390 https://doi.org/10.1016/j.gene.2019.02.066
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3886 https://portal.issn.org/resource/ISSN/0378-1119
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer
discusses	http://id.nlm.nih.gov/mesh/M0407989 http://id.nlm.nih.gov/mesh/M0472526 http://id.nlm.nih.gov/mesh/M0516469 http://id.nlm.nih.gov/mesh/M0178953 http://id.nlm.nih.gov/mesh/M0030068 http://id.nlm.nih.gov/mesh/M0026156
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D053594Q000378 http://id.nlm.nih.gov/mesh/D053594Q000235 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D035683Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D017239 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D020413 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D009368 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D002465 http://id.nlm.nih.gov/mesh/D001943Q000235 http://id.nlm.nih.gov/mesh/D001943Q000378 http://id.nlm.nih.gov/mesh/D061986 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D015972 http://id.nlm.nih.gov/mesh/D049109
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_287e4a9e171dd73d65a6f71ce6a5d407 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID406947 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4615

Showing number of triples: 1 to 66 of 66.